Application Nr Approved Date Route Status External Links
ANDA206856 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Tranylcypromine Tablets Are Indicated For The Treatment Of Major Depressive Disorder (Mdd) In Adult Patients Who Have Not Responded Adequately To Other Antidepressants. Tranylcypromine Tablets Are Not Indicated For The Initial Treatment Of Mdd Due To The Potential For Serious Adverse Reactions And Drug Interactions, And The Need For Dietary Restrictions [See Contraindications (4), Warnings And Precautions (5) , And Drug Interactions (7)]. Tranylcypromine Tablets Are A Monoamine Oxidase Inhibitor (Maoi) Indicated For The Treatment Of Major Depressive Disorder (Mdd) In Adult Patients Who Have Not Responded Adequately To Other Antidepressants ( 1 ) Tranylcypromine Tablets Are Not Indicated For The Initial Treatment Of Mdd Due To The Potential For Serious Adverse Reactions And Drug Interactions, And The Need For Dietary Restrictions ( 1 , 4 , 5 , 7 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Tranylcypromine Sulfate TRANYLCYPROMINE SULFATE ZINC896663

Comments